A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01691846
Recruitment Status : Completed
First Posted : September 25, 2012
Last Update Posted : February 23, 2017
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2013
  Study Completion Date : September 2013
  Certification/Extension First Submitted : August 9, 2016